Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dexamethasone sodium phosphate
Advanz Pharma
H02AB02
Dexamethasone sodium phosphate
2mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 5060064792629
PACKAGE LEAFLET: INFORMATION FOR THE USER DEXAMETHASONE 10MG/5ML ORAL SOLUTION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you take this medicine for more than three weeks, you will get a blue ‘steroid card’: always keep it with you and show it to any doctor, dentist, nurse, midwife or anyone else who is giving you treatment. - If you get any side effects talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. What is in this leaflet: 1. What Dexamethasone Oral Solution is and what it is used for 2. What you need to know before you take Dexamethasone Oral Solution 3. How to take Dexamethasone Oral Solution 4. Possible side-effects 5. How to store Dexamethasone Oral Solution 6. Contents of the pack and other information 1. WHAT DEXAMETHASONE ORAL SOLUTION IS AND WHAT IT IS USED FOR Dexamethasone Oral Solution contains the active substance dexamethasone. Dexamethasone belongs to a group of medicines called steroids (the full name is corticosteroids). Corticosteroids occur naturally in the body, and help to maintain health and well-being. Boosting your body with extra corticosteroid (such as dexamethasone) is an effective way to treat various illnesses involving inflammation in the body. Dexamethasone Oral Solution reduces this inflammation, which could otherwise go on making your condition worse. You must take this medicine regularly to get maximum benefit from it. DEXAMETHASONE ORAL SOLUTION IS USED FOR ONE OF THE FOLLOWING: • where your natural corticosteroid levels have been reduced and you need to replace them • where swelling of the brain has occurred • if you are having tests for diseases which may decrease your Διαβάστε το πλήρες έγγραφο
OBJECT 1 DEXAMETHASONE 10MG/5ML ORAL SOLUTION Summary of Product Characteristics Updated 04-May-2018 | Concordia International- formerly Focus Pharmaceuticals Ltd 1. Name of the medicinal product Dexamethasone 10mg/5ml Oral Solution 2. Qualitative and quantitative composition Each 5ml of solution contains 10mg of dexamethasone (as dexamethasone sodium phosphate). Excipients with known effect Each 5ml of solution also contains 1375mg liquid maltitol (E965) and 700mg sorbitol (E420). For the full list of excipients, see section 6.1 3. Pharmaceutical form Oral Solution A colourless to yellowish solution with a mint odour. 4. Clinical particulars 4.1 Therapeutic indications Dexamethasone is a corticosteroid. It is designed for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction. Endocrine disorders: Endocrine exophthalmos. Non-endocrine disorders: Dexamethasone may be used in the treatment of non-endocrine corticosteroid responsive conditions including: Allergy and anaphylaxis: Anaphylaxis. Arteritis collagenosis: Polymyalgia rheumatica, polyarteritis nodosa. Haematological disorders: Haemolytic anaemia (also auto immune), leukaemia, myeloma, idiopathic thrombocytopenic purpura in adults, reticulolymphoproliferative disorders (see also under oncological disorders). Gastroenterological disorders: For treatment during the critical stage in: ulcerative colitis (rectal only); regional enteritis (Crohn's disease), certain forms of hepatitis. Muscular disorders: Polymyositis. Neurological disorders: Raised intra-cranial pressure secondary to cerebral tumours, acute exacerbations of multiple sclerosis. Ocular disorders: Anterior and posterior uveitis, optic neuritis, chorioretinitis, iridocyclitis, temporal arteritis, orbital pseudotumour. Renal disorders: Nephrotic syndrome. Pulmonary disorders: Chronic bronchial asthma, aspiration pneumonitis, chronic obstructive pulmonary disease (COPD), sarcoidosis, allergic pulmonary diseas Διαβάστε το πλήρες έγγραφο